Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-10

Clinical Trial Update: Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial investigates glutathione's effects on brain metabolism and inflammation in Alzheimer's disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glutathione (glutathione)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Alzheimer Disease | EARLY_Phase 1 | Status: RECRUITING